Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies

The aim of this study was to compare the efficacy and retention rates of three biologics (abatacept, tocilizumab, and etanercept) after switching from first-course anti-TNF monoclonal antibody therapy. We performed a retrospective multicenter study of 89 patients who underwent second-course biologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirabara, Shinya, Takahashi, Nobunori, Fukaya, Naoki, Miyake, Hiroyuki, Yabe, Yuichiro, Kaneko, Atsushi, Ito, Takayasu, Oguchi, Takeshi, Kida, Daihei, Hirano, Yuji, Fujibayashi, Takayoshi, Sugiura, Fumiaki, Hayashi, Masatoshi, Funahashi, Koji, Hanabayashi, Masahiro, Asai, Shuji, Ishiguro, Naoki, Kojima, Toshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138439/
https://www.ncbi.nlm.nih.gov/pubmed/24970596
http://dx.doi.org/10.1007/s10067-014-2711-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138439/
https://www.ncbi.nlm.nih.gov/pubmed/24970596
http://dx.doi.org/10.1007/s10067-014-2711-2

Ejemplares similares